Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma

Figure 5

Survival analysis according to GILncSig in different clinicopathological features. (a–h) The K-M analysis according to GILncSig for patients with various clinical features as younger than 65, older than 65, male, female, G1-2, G3-4, T1-2, T3-4. For patients younger than 65, male, G1-2, G3-4, T1-2, T3-4, K-M analysis revealed that the OS in the low-risk group was significantly better than the high-risk group. However, for patients older than 65 or female, there was no significant difference in OS between the high-risk and low-risk groups.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)